ShareValue.ai

ShareValue scores for UNICHEMLAB.NSE: Valuation 86, Quality 34, Growth 45, Health 47.

UNICHEMLAB.NSE
NSE

Unichem Laboratories Limited

₹461.70(+2.10%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

14% to 30%
Valuation
86
Undervalued
Price vs Value
Quality
34
Weak
Business Strength
Growth
45
Moderate
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
69
Bullish
Price Trend

Company Details

About

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited.

Score Analysis

AI Investment Thesis

Data as of:Jul 1, 2026
|
Last calculated:Jul 1, 2026